The extent of lymph node dissection for melanoma when analyzed by quartiles is an independent factor in overall survival. This factor appears to be more important with increasing tumor burden in the lymphatic basin. The extent of lymph node dissection should be considered as a prognostic factor in the design of clinical trials that involve stage III melanoma.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2000) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: